Naoko Minegishi Selected Research

chemotactic factor inactivator

6/2023

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoko Minegishi Research Topics

Disease

5	Anemia 01/2017 - 01/2011
4	Hypoxia (Hypoxemia) 01/2013 - 03/2006
2	Postpartum Depression (Post-Natal Depression) 08/2023 - 12/2022
2	Fibrosis (Cirrhosis) 10/2013 - 10/2011
1	Atypical Hemolytic Uremic Syndrome 06/2023
1	Thrombotic Microangiopathies 06/2023
1	Hemolysis 06/2023
1	Necrosis 05/2022
1	Ulcerative Colitis 01/2022
1	Genetic Risk Score 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Diarrhea 01/2022
1	Fever (Fevers) 01/2022
1	Confusion (Bewilderment) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2019
1	Aneurysm (Aneurysms) 07/2019
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2019
1	Pregnancy Complications 01/2019
1	Neoplasms (Cancer) 10/2018
1	Carcinogenesis 03/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2012
1	Hyperglycemia 12/2012
1	Left Ventricular Dysfunction 04/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2006
1	Pulmonary Hypertension 03/2006
1	Hematologic Diseases (Blood Diseases) 11/2003

Drug/Important Bio-Agent (IBA)

9	Erythropoietin FDA Link 01/2017 - 03/2006
2	Tuberculin (PPD)IBA 08/2023 - 12/2022
2	AntibodiesIBA 06/2023 - 05/2022
1	CytokinesIBA 08/2023
1	Complement System Proteins (Complement)IBA 06/2023
1	Complement Factor H (Factor H)IBA 06/2023
1	chemotactic factor inactivatorIBA 06/2023
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022
1	P-2 (P 2)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Polysaccharides (Glycans)IBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2019
1	ProteomeIBA 01/2019
1	human ERBB2 proteinIBA 10/2018
1	Carcinoembryonic AntigenIBA 10/2018
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 10/2018
1	ClathrinIBA 03/2013
1	Streptozocin (Streptozotocin)FDA Link 12/2012
1	calpastatinIBA 12/2012
1	CalpainIBA 12/2012
1	calpain inhibitorsIBA 12/2012
1	NF-E2 Transcription FactorIBA 12/2012
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2011
1	Hormones (Hormone)IBA 10/2011
1	Tamoxifen FDA LinkGeneric 10/2011
1	Myelin P0 Protein (Myelin Protein Zero)IBA 10/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2006
1	Proteins (Proteins, Gene)FDA Link 11/2003
1	GATA Transcription FactorsIBA 11/2003

Therapy/Procedure

1	Therapeutics 07/2019